Feature | January 31, 2012 | Helen Kuhl

Breast MRI Continues to Gain Support

This article appeared as the introduction to a chart on breast MRI systems in the January/February 2012 issue.

The AuroraEDGE breast MRI system

Magnetic resonance imaging (MRI) of the breast continues to get more play as an important adjunct to mammography in screening for cancer, as its diagnostic value is recognized particularly for young women with dense breast tissue.

“MRI of the breast offers valuable information about many breast conditions that cannot be obtained by other imaging modalities, such as mammography or ultrasound,” says radiologyinfo.org, the website for patients developed by the American College of Radiology (ACR) and Radiological Society of North America (RSNA). Since 2007, the American Cancer Society has been recommending that women at high risk for breast cancer get an MRI along with their yearly mammograms, and that women at moderately increased risk (this category includes women with dense or unevenly dense breasts) discuss adding MRI with their physician.

The dense breast issue is likely to remain in the spotlight into the near future, as legislative efforts are underway to require that women be given information about breast density and potential risks in their mammogram reports. Texas and Connecticut already have laws in that regard. California passed a similar bill that was subsequently vetoed by Governor Jerry Brown, but one is likely to be reintroduced in some form. And nationally, the “Breast Density and Mammography Reporting Act of 2011” (H.R. 3102.I.H.), with similar recommendations, was introduced in October 2011, sponsored by Rosa L. DeLauro (D-CT). It currently is being reviewed by the Subcommittee on Health.

Since MRI does not involve ionizing radiation, the safety of the screening is not really a factor. But it is an expensive exam, and it cannot detect calcifications as mammography does. So it is never recommended as a replacement for mammograms.

“If MRI is used, it should be in addition to, not instead of, a screening mammogram. This is because although an MRI is a more sensitive test (it’s more likely to detect cancer than a mammogram), it may still miss some cancers that a mammogram would detect,” say the ACS guidelines.

Also, because of its low specificity, breast MRI does have a higher rate of false-positive results, which can become a factor as to whether or not a woman has the exam. However, recent studies looking at MRI in various scenarios have been published and underscore its benefits.

One study pertaining to the false-positive issue found that MRI screening for breast cancer delivers consistent rates of cancer detection and fewer false-positive results over time. “The goal of our study was to determine if the availability of prior MR images for comparison reduces the rate of false-positives associated with the initial MRI breast screening exam,” said the study’s co-author, Martha B. Mainiero, M.D., director of the Anne C. Pappas Center for Breast Imaging at Rhode Island Hospital and associate professor of diagnostic imaging at The Warren Alpert Medical School of Brown University in Providence, R.I. (www.itnonline.com/article/repeat-mri-screening-breast-cancer-results-fewer-false-positives)

The study results, published in February in Radiology, showed that the rate of false-positives decreases following the initial round of screening.

Another study published in Radiology the same month showed that breast cancer screening with MRI can detect invasive cancers missed on mammography in women who have undergone chest irradiation for other diseases.

“Our results support existing recommendations for annual screening MRI as an adjunct to annual mammography in women with a history of chest irradiation,” said the study’s lead author, Janice S. Sung, M.D., radiologist at Memorial Sloan-Kettering Cancer Center in New York City. (www.itnonline.com/article/breast-cancer-screening-mri-benefits-women-radiation-therapy-history)

Stretching the reach of MRI for breast screening further is Dr. Steven Harms, M.D., FACR, medical director for Aurora Imaging Technology, who has been using Aurora breast MRI for the detection of all grades of ductal carcinoma in situ (DCIS). “I have been employing this technology at my practice for slightly more than two years now and have seen the clinical benefit it provides,” Harms wrote in an article that appeared in the June 2011 of ITN. “In a recent evaluation of clinical cases, the Aurora system detected 19 of 20 pathology-proven DCIS cases, nearly half of which were intermediate or low-grade.”

Breast MRI also is recognized as an excellent imaging modality for evaluating silicone breast implants. It often is used to detect or examine ruptures.

Related Content

Breast Cancer Screening Performance Impacted by Mean Mammographic Compression Pressure
News | Mammography | December 08, 2017
Dutch researchers demonstrated a strong relationship between compression pressure in mammography and breast cancer...
Sponsored Content | Videos | Mammography | December 06, 2017
Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre,
Ikonopedia and Konica Minolta Showcase Integrated Breast Imaging Workflow and Reporting at RSNA
News | Breast Imaging | December 05, 2017
Ikonopedia and Konica Minolta Healthcare Americas Inc. showcased integrated breast imaging workflow and reporting at...
Sponsored Content | Videos | Breast Imaging | December 05, 2017
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, attending radiologis
Numerous Studies Highlight Importance of Quantitative Breast Imaging Analysis at RSNA 2017
News | Breast Density | November 30, 2017
The importance of quantitative analysis in breast imaging was the focus of numerous abstracts accepted for presentation...
Hologic Receives FDA 510(k) Clearance of Quantra 2.2 Breast Density Assessment Software
Technology | Breast Density | November 28, 2017
Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...
Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography
Technology | November 20, 2017
Eizo Corp. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis...
Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

Biop Medical cervical cancer detection system

Technology | Women's Health | November 13, 2017
November 13, 2017 — Biop Medical announced it will present its point-of-care...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Kubtec Brings Image Analytics Capabilities to Tomosynthesis Specimen Imaging Systems
News | Mammography | November 10, 2017
Kubtec announced it will be showcasing new image analytics capabilities on its advanced tomosynthesis specimen imaging...
Overlay Init